Hint mode is switched on Switch off
For swift navigation between sections

Par Pharmaceutical Inc.
LEI 549300KK5WR4MGN4YT97

PDF download

Choose all Reset all
Download Cancel
The issuer's bonds defaulted in 2022
Organization name
Par Pharmaceutical, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
1,500 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Par Pharmaceutical, Inc. operates as a generic pharmaceutical company. The Company develops, manufactures, and markets generic pharmaceutical and branded injectable products.

Awards

Documentation

Stocks

Latest issues

Show all

Bond classification

  • Organization does not disclose IFRS/US GAAP financial statements

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300KK5WR4MGN4YT97
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0000728351
Registration is required to get access.